Detalhe da pesquisa
1.
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica
; 104(1): e4-e8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076178
2.
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.
Cancer Med
; 8(18): 7567-7576, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657156